Healthcare News
New and Experimental Therapies for Rheumatoid Arthritis
New therapies for rheumatoid arthritis, including Janus kinase (JAK) inhibitors and Bruton’s tyrosine kinase (BTK) inhibitors, hold promise in reducing inflammation and alleviating symptoms. Experimental approaches like vagus nerve stimulation are also being explored to further improve patient outcomes.
Source: Verywell health
Frailty may predict osteoporotic fracture in US veterans with rheumatoid arthritis
Frailty is a predictor of incident osteoporotic fracture among patients with rheumatoid arthritis, according to an analysis of data from the Veterans Affairs Rheumatoid Arthritis registry.
Source: Healio
Drug reduces the risk of developing rheumatoid arthritis, clinical trial finds
A clinical trial led by researchers from Hospital Cl?nic de Barcelona, the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and the Institute of Advanced Chemistry of Catalonia (IQAC-CSIC) compared the effectiveness of abatacept and hydroxychloroquine in preventing the development of rheumatoid arthritis in patients with palindromic rheumatism, an autoimmune disease that progresses to arthritis in approximately half of all patients.
Source: Medical Xpress
New study points to possible new treatment for rheumatoid arthritis
There is good news for patients with rheumatoid arthritis. Research from Aarhus University and Aarhus University Hospital may have opened the door to an entirely new way of reducing inflammation in the joints. The study is published in the journal EULAR Rheumatology Open.
Source: Medical Xpress
Taltz plus Zepbound superior to Taltz alone in psoriatic arthritis alongside obesity
Treatment with ixekizumab plus tirzepatide achieves greater disease control, physical function and weight loss vs. monotherapy in patients with psoriatic arthritis and obesity, according to data published in Arthritis & Rheumatology.
Source: Healio
